The interaction between epigenetics, nutrition and the development of cancer

Nutrients

Volumn 7, Issue 2, 2015, Pages 922-947

  Bishop, Karen S ^a   Ferguson, Lynnette R ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Breast cancer; Colon cancer; Epigenetics; Methyl donors; Nutrition; Prostate cancer

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CAFFEIC ACID; CINNAMIC ACID; DAIDZEIN; FOLIC ACID; GENISTEIN; GREEN TEA EXTRACT; ISOTHIOCYANIC ACID; LIGNAN; LYCOPENE; METHYL CPG BINDING PROTEIN; MICRORNA; ONCOSTATIN M RECEPTOR BETA; POLYPHENOL; RESVERATROL; SELENIUM; SMALL UNTRANSLATED RNA; SULFORAPHANE; VITAMIN D; HISTONE;

BREAST CANCER; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL EFFECTIVENESS; COLON CANCER; COLORECTAL CANCER; DIET; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; LEAFY VEGETABLE; NEOPLASM; NUTRITION; PROSTATE CANCER; REVIEW; GENETIC EPIGENESIS; GENETICS; METABOLISM; NUTRITIONAL STATUS; RISK FACTOR;

DIET; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; HISTONES; HUMANS; MICRORNAS; NEOPLASMS; NUTRITIONAL STATUS; RISK FACTORS;

EID: 84961288801     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7020922     Document Type: Review

References (156)

1. Burger, G.C.E.; Sandstead, H.R.; Drummond, J. Starvation in Western Holland: 1945. Lancet 1945, 246, 282–283.
2. Barrera, L.N.; Cassidy, A.; Johnson, I.T.; Bao, Y.; Belshaw, N.J. Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: Potential implications for cancer chemoprevention. Proc. Nutr. Soc. 2012, 71, 237–245.
3. Bygren, L.O.; Tinghog, P.; Carstensen, J.; Edvinsson, S.; Kaati, G.; Pembrey, M.E.; Sjostrom, M. Change in paternal grandmothers’ early food supply influenced cardiovascular mortality of the female grandchildren. BMC Genet. 2014, 15, 12.
4. Berner, C.; Aumuller, E.; Gnauck, A.; Nestelberger, M.; Just, A.; Haslberger, A.G. Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann. Nutr. Metab. 2010, 57, 183–189.
5. Youngson, N.A.; Whitelaw, E. Transgenerational epigenetic effects. Annu. Rev. Genomics Hum. Genet. 2008, 9, 233–257.
6. Fraga, M.F.; Ballestar, E.; Paz, M.F.; Ropero, S.; Setien, F.; Ballestar, M.L.; Heine-Suner, D.; Cigudosa, J.C.; Urioste, M.; Benitez, J.; et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA 2005, 102, 10604–10609.
7. Supic, G.; Jagodic, M.; Magic, Z. Epigenetics: A New Link Between Nutrition and Cancer. Nutr. Cancer 2013, 65, 781–792.
8. Faulk, C.; Dolinoy, D.C. Timing is everything: The when and how of environmentally induced changes in the epigenome of animals. Epigenetics Off. J. DNA Methylation Soc. 2011, 6, 791–797.
9. Jiménez-Chillarón, J.C.; Díaz, R.; Martínez, D.; Pentinat, T.; Ramón-Krauel, M.; Ribó, S.; Plösch, T. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 2012, 94, 2242–2263.
10. Hughes, L.A.E.; van den Brandt, P.A.; de Bruïne, A.P.; Wouters, K.A.D.; Hulsmans, S.; Spiertz, A.; Goldbohm, R.A.; de Goeij, A.F.P.M.; Herman, J.G.; Weijenberg, M.P.; et al. Early Life Exposure to Famine and Colorectal Cancer Risk: A Role for Epigenetic Mechanisms. PLoS One 2009, 4, e7951.
11. Heijmans, B.T.; Tobi, E.W.; Stein, A.D.; Putter, H.; Blauw, G.J.; Susser, E.S.; Slagboom, P.E.; Lumey, L.H. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. USA 2008, 105, 17046–17049.
12. Schulz, L.C. The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. USA 2010, 107, 16757–16758.
13. Kyle, U.G.; Pichard, C. The Dutch Famine of 1944–1945: A pathophysiological model of longterm consequences of wasting disease. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 388–394.
14. Pembrey, M.; Bygren, L.; Golding, J. The Nature of Human Transgenerational Responses. In Environmental Epigenomics in Health and Disease; Springer Berlin Heidelberg: Berlin, Germany, 2013; pp. 257–271.
15. Lillycrop, K.A.; Burdge, G.C. Epigenetic mechanisms linking early nutrition to long term health. Best Pract. Res. Clin. Endocr. Metab. 2012, 26, 667–676.
16. Rayman, M.P. Selenium in cancer prevention: A review of the evidence and mechanism of action. Proc. Nutr. Soc. 2005, 64, 527–542.
17. Yamaji, T.; Inoue, M.; Sasazuki, S.; Iwasaki, M.; Kurahashi, N.; Shimazu, T.; Tsugane, S.; Japan Public Health Center-based Prospective Study Group. Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan: The JPHC study. Int. J. Cancer 2008, 123, 1935–1940.
18. Juge, N.; Mithen, R.F.; Traka, M. Molecular basis for chemoprevention by sulforaphane: A comprehensive review. Cell. Mol. Life Sci. 2007, 64, 1105–1127.
19. American Institute for Cancer Research. Preventing Colon Cancer: Six Steps to Reduce Your Risk; Available online: http://www.aicr.org/press/press-releases/preventing-colon-cancer-6-steps.html (accessed on 7 July 2014).
20. Teegarden, D.; Romieu, I.; Lelièvre, S.A. Redefining the impact of nutrition on breast cancer incidence: Is epigenetics involved? Nutr. Res. Rev. 2012, 25, 68–95.
21. Ramadas, A.; Chan, C.K.; Oldenburg, B.; Hussien, Z.; Quek, K. A Web-Based Dietary Intervention for People with Type 2 Diabetes: Development, Implementation, and Evaluation. Int. J. Behav. Med. 2014, 1–9, doi:10.1007/s12529-014-9445-z.
22. Kristal, A.R.; Beresford, S.A.; Lazovich, D. Assessing change in diet-intervention research. Am. J. Clin. Nutr. 1994, 59, 185S–189S.
23. Kristal, A.R.; Peters, U.; Potter, J.D. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol. Biomark. Prev. 2005, 14, 2826–2828.
24. Brunner, E.; Stallone, D.; Juneja, M.; Bingham, S.; Marmot, M. Dietary assessment in Whitehall II: Comparison of 7 d diet diary and food-frequency questionnaire and validity against biomarkers. Br. J. Nutr. 2001, 86, 405–414.
25. Buzzard, I.M.; Faucett, C.L.; Jeffery, R.W.; McBane, L.; McGovern, P.; Baxter, J.S.; Shapiro, A.C.; Blackburn, G.L.; Chlebowski, R.T.; Elashoff, R.M.; et al. Monitoring dietary change in a low-fat diet intervention study: Advantages of using 24-h dietary recalls vs. food records. J. Am. Diet. Assoc. 1996, 96, 574–579.
26. Day, N.; McKeown, N.; Wong, M.; Welch, A.; Bingham, S. Epidemiological assessment of diet: A comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int. J. Epidemiol. 2001, 30, 309–317.
27. Shukla, S.; Meeran, S.M.; Katiyar, S.K. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett. 2014, 355, 9–17.
28. Cooper, D.N.; Youssoufian, H. The CpG dinucleotide and human genetic disease. Hum. Genet. 1988, 78, 151–155.
29. Cui, H.; Horon, I.L.; Ohlsson, R.; Hamilton, S.R.; Feinberg, A.P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 1998, 4, 1276–1280.
30. Cruz-Correa, M.; Cui, H.; Giardiello, F.M.; Powe, N.R.; Hylind, L.; Robinson, A.; Hutcheon, D.F.; Kafonek, D.R.; Brandenburg, S.; Wu, Y.; et al. Loss of imprinting of insulin growth factor II gene: A potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004, 126, 964–970.
31. Ji, W.; Hernandez, R.; Zhang, X.Y.; Qu, G.Z.; Frady, A.; Varela, M.; Ehrlich, M. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat. Res. 1997, 379, 33–41.
32. Suter, C.; Martin, D.; Ward, R. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 2004, 19, 95–101.
33. Herman, J.G.; Baylin, S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349, 2042–2054.
34. Cheng, J.C.; Matsen, C.B.; Gonzales, F.A.; Ye, W.; Greer, S.; Marquez, V.E.; Jones, P.A.; Selker, E.U. Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine. J. Natl Cancer Inst. 2003, 95, 399–409.
35. Davis, C.D.; Uthus, E.O. Dietary Selenite and Azadeoxycytidine Treatments Affect Dimethylhydrazine-Induced Aberrant Crypt Formation in Rat Colon and DNA Methylation in HT-29 Cells. J. Nutr. 2002, 132, 292–297.
36. Qin, W.; Zhang, K.; Clarke, K.; Weiland, T.; Sauter, E.R. Methylation and miRNA Effects of Resveratrol on Mammary Tumors vs. Normal Tissue. Nutr. Cancer 2014, 66, 270–277.
37. Jin, W.; Lee, J.J.; Kim, M.S.; Son, B.H.; Cho, Y.K.; Kim, H.P. DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2011, 406, 89–95.
38. Yang, J.; Ji, W.; Qu, Y.; He, L.; Zhao, X. Study of RASSF1A expression and promoter demethylation in Hep-2 cell line. J. Clin. Otorhinolaryngol. Head Neck Surg. 2011, 25, 64–66.
39. Rodriguez, R.M.; Huidobro, C.; Urdinguio, R.G.; Mangas, C.; Soldevilla, B.; Domínguez, G.; Bonilla, F.; Fernandez, A.F.; Fraga, M.F. Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer. J. Mol. Med. 2012, 90, 587–595.
40. Fandy, T.E.; Herman, J.G.; Kerns, P.; Jiemjit, A.; Sugar, E.A.; Choi, S.-H.; Yang, A.S.; Aucott, T.; Dauses, T.; Odchimar-Reissig, R.; et al. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. Blood 2009, 114, 2764–2773.
41. Kim, M.S.; Louwagie, J.; Carvalho, B.; Terhaar Sive Droste, J.S.; Park, H.L.; Chae, Y.K.; Yamashita, K.; Liu, J.; Ostrow, K.L.; Ling, S.; et al. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 2009, 4, e6555.
42. Ahmed, D.; Danielsen, S.A.; Aagesen, T.H.; Bretthauer, M.; Thiis-Evensen, E.; Hoff, G.; Rognum, T.O.; Nesbakken, A.; Lothe, R.A.; Lind, G.E. A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin. Transl. Gastroenterol. 2012, 3, e27.
43. Deng, G.; Kakar, S.; Okudiara, K.; Choi, E.; Sleisenger, M.H.; Kim, Y.S. Unique Methylation Pattern of Oncostatin M Receptor Gene in Cancers of Colorectum and Other Digestive Organs. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2009, 15, 1519–1526.
44. Hibi, K.; Goto, T.; Sakuraba, K.; Shirahata, A.; Saito, M.; Ishibashi, K.; Kigawa, G.; Nemoto, H.; Sanada, Y. Methylation of OSMR Gene Is Frequently Observed in Non-invasive Colorectal Cancer. Anticancer Res. 2011, 31, 1293–1295.
45. Duthie, S.J. Epigenetic modifications and human pathologies: Cancer and CVD. Proc. Nutr. Soc. 2011, 70, 47–56.
46. Kim, M.S.; Lee, J.; Sidransky, D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev. 2010, 29, 181–206.
47. Allis, C.D.; Jenuwein, T.; Reinberg, D. Overview and Concepts. In Epigenetics; John Inglis: New York, NY, USA, 2007; pp. 23–61.
48. Kramer, J.M. Epigenetic regulation of memory: Implications in human cognitive disorders. BMC 2013, 4, 1–12.
49. Luger, K. Structure and dynamic behavior of nucleosomes. Curr. Opin. Genet. Dev. 2003, 13, 127–135.
50. Toraño, E.G.; Fernandez, A.F.; Urdinguio, R.G.; Fraga, M.F. Role of Epigenetics in Neural Differentiation: Implications for Health and Disease. In Molecular Mechanisms and Physiology of Disease; Springer: New York, NY, USA, 2014.
51. Pan, Y.-X.; Zhang, Y.; Chen, D. Epigenetic Mechanisms of Colon Cancer Prevention: What Can Nutrition Do? In Molecular Mechanisms and Physiology of Disease; Springer: New York, NY, USA, 2014; pp. 277–353.
52. Xu, W.S.; Parmigiani, R.B.; Marks, P.A. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 2007, 26, 5541–5552.
53. Mathews, L.A.; Crea, F.; Farrar, W.L. Epigenetic gene regulation in stem cells and correlation to cancer. Differ. Res. Biol. Divers. 2009, 78, 1–17.
54. Paolicchi, E.; Crea, F.; Farrar, W.L.; Green, J.E.; Danesi, R. Histone lysine demethylases in breast cancer. Crit. Rev. Oncol. Hematol. 2013, 86, 97–103.
55. Bianco-Miotto, T.; Chiam, K.; Buchanan, G.; Jindal, S.; Day, T.K.; Thomas, M.; Pickering, M.A.; O’Loughlin, M.A.; Ryan, N.K.; Raymond, W.A.; et al. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol. Biomark. Prev. 2010, 19, 2611–2622.
56. Chen, Z.; Wang, L.; Wang, Q.; Li, W. Histone modifications and chromatin organization in prostate cancer. Epigenomics 2010, 2, 551–560.
57. Rajendran, P.; Delage, B.; Dashwood, W.M.; Yu, T.W.; Wuth, B.; Williams, D.E.; Ho, E.; Dashwood, R.H. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: Competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol. Cancer 2011, 10, 68.
58. Ashktorab, H.; Belgrave, K.; Hosseinkhah, F.; Brim, H.; Nouraie, M.; Takkikto, M.; Hewitt, S.; Lee, E.; Dashwood, R.H.; Smoot, D. Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma. Dig. Dis. Sci. 2009, 54, 2109–2117.
59. Liloglou, T.; Bediaga, N.G.; Brown, B.R.; Field, J.K.; Davies, M.P. Epigenetic biomarkers in lung cancer. Cancer Lett. 2014, 342, 200–212.
60. Friedman, R.C.; Farh, K.K.-H.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19, 92–105.
61. Lopez-Serra, P.; Esteller, M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene 2012, 31, 1609–1622.
62. Lujambio, A.; Ropero, S.; Ballestar, E.; Fraga, M.F.; Cerrato, C.; Setién, F.; Casado, S.; Suarez-Gauthier, A.; Sanchez-Cespedes, M.; Gitt, A.; et al. Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells. Cancer Res. 2007, 67, 1424–1429.
63. Wilting, S.; van Boerdonk, R.; Henken, F.; Meijer, C.; Diosdado, B.; Meijer, G.; le Sage, C.; Agami, R.; Snijders, P.; Steenbergen, R. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol. Cancer 2010, 9, 167.
64. Ando, T.; Yoshida, T.; Enomoto, S.; Asada, K.; Tatematsu, M.; Ichinose, M.; Sugiyama, T.; Ushijima, T. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect. Int. J. Cancer J. Int. Cancer 2009, 124, 2367–2374.
65. Van Wolfswinkel, J.C.; Ketting, R.F. The role of small non-coding RNAs in genome stability and chromatin organization. J. Cell Sci. 2010, 123, 1825–1839.
66. Li, Y.; Kong, D.; Ahmad, A.; Bao, B.; Dyson, G.; Sarkar, F.H. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Epigenetics Off. J. DNA Methylation Soc. 2012, 7, 940–949.
67. Ma, L.; Teruya-Feldstein, J.; Weinberg, R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449, 682–688.
68. Suh, S.O.; Chen, Y.; Zaman, M.S.; Hirata, H.; Yamamura, S.; Shahryari, V.; Liu, J.; Tabatabai, Z.L.; Kakar, S.; Deng, G.; et al. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis 2011, 32, 772–778.
69. Lujambio, A.; Esteller, M. How epigenetics can explain human metastasis: A new role for microRNAs. Cell Cycle 2009, 8, 377–382.
70. Verma, M. Cancer control and prevention by nutrition and epigenetic approaches. Antioxid. Redox Signal. 2012, 17, 355–364.
71. Fang, M.Z.; Chen, D.; Sun, Y.; Jin, Z.; Christman, J.K.; Yang, C.S. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer Res. 2005, 11, 7033–7041.
72. Chen, M.; Rao, Y.; Zheng, Y.; Wei, S.; Li, Y.; Guo, T.; Yin, P. Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: A meta-analysis of epidemiological studies. PLoS One 2014, 9, e89288.
73. Dolinoy, D.C.; Weidman, J.R.; Waterland, R.A.; Jirtle, R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 2006, 114, 567–572.
74. Dolinoy, D.C.; Huang, D.; Jirtle, R.L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc. Natl. Acad. Sci. USA 2007, 104, 13056–13061.
75. Zhu, W.; Qin, W.; Zhang, K.; Rottinghaus, G.E.; Chen, Y.-C.; Kliethermes, B.; Sauter, E. R. Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast Cancer. Nutr. Cancer 2012, 64, 393–400.
76. Berletch, J.B.; Liu, C.; Love, W.K.; Andrews, L.G.; Katiyar, S.K.; Tollefsbol, T.O. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J. Cell. Biochem. 2008, 103, 509–519.
77. Fang, M.Z.; Wang, Y.; Ai, N.; Hou, Z.; Sun, Y.; Lu, H.; Welsh, W.; Yang, C.S. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 2003, 63, 7563–7570.
78. Nandakumar, V.; Vaid, M.; Katiyar, S.K. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis 2011, 32, 537–544.
79. Kim, S.O.; Kim, M.R. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int. J. Oncol. 2013, 42, 349–358.
80. Holst, B.; Williamson, G. A critical review of the bioavailability of glucosinolates and related compounds. Nat. Prod. Rep. 2004, 21, 425-447.
81. Verkerk, R.; Schreiner, M.; Krumbein, A.; Ciska, E.; Holst, B.; Rowland, I.; de Schrijver, R.; Hansen, M.; Gerhauser, C; Mithen, R.; Dekker, M. Glucosinolates in Brassica vegetables: The influence of the food supply chain on intake, bioavailability and human health. Mol. Nutr. Food Res. 2009, 53 (Suppl. 2), S219.
82. Yan, H.; Zhu, Y.; Liu, B.; Wu, H.; Li, Y.; Wu, X.; Zhou, Q.; Xu, K. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br. J. Nutr. 2011, 106, 1779-1791.
83. Steegers-Theunissen, R.P.; Obermann-Borst, S.A.; Kremer, D.; Lindemans, J.; Siebel, C; Steegers, E.A.; Slagboom, P.E.; Heijmans, B.T. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009, 4, e7845.
84. Coppedè, F. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Cancer Lett. 2014, 342, 238-247.
85. Han, C.T.; Schoene, N.W.; Lei, K.Y. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells. Am. J. Physiol. Cell Physiol. 2009, 297, C1188-C1199.
86. Wan, S.G.; Taccioli, C; Jiang, Y.; Chen, H.; Smalley, K.J.; Huang, K.; Liu, X.P.; Farber, J.L.; Croce, CM.; Fong, L.Y. Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. Int. J. Cancer 2011, 129, 331-345.
87. Liang, J.Y.; Liu, Y.Y.; Zou, J.; Franklin, R.B.; Costello, L.C.; Feng, P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999, 40, 200-207.
88. Bommareddy, A.; Arasada, B.L.; Mathees, D.P.; Dwivedi, C. Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr. Cancer 2006, 54, 216-222.
89. Eilati, E.; Bahr, J.; Hales, D. Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E2 in hens. Gynecol. Oncol. 2013, 130, 620-628.
90. He, F.; Lupu, D.S.; Niculescu, M.D. Perinatal α-linolenic acid availability alters the expression of genes related to memory and to epigenetic machinery, and the Mecp2 DNA methylation in the whole brain of mouse offspring. Int. J. Dev. Neurosci. 2014, 36, 38-44.
91. Makrides, M.; Collins, C.T.; Gibson, R.A. Impact of fatty acid status on growth and neurobehavioural development in humans. Matern. Child. Nutr. 2011, 7, 80-88.
92. Hong, S.K.; Kim, J.H.; Lin, M.F.; Park, J.I. The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. Exp. Cell Res. 2011, 317, 2671-2682.
93. Romagnolo, D.F.; Papoutsis, A.J.; Selmin, O. Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention. Inflamm. Allergy Drug Targets 2010, 9, 181-191.
94. Hoile, S.P.; Irvine, N.A.; Kelsall, C.J.; Sibbons, C; Feunteun, A.; Collister, A.; Torrens, C; Calder, P.C.; Hanson, M.A.; Lillycrop, K.A.; et al. Maternal fat intake in rats alters 20:4n-6 and 22:6n-3 status and the epigenetic regulation of Fads2 in offspring liver. J. Nutr. Biochem. 2013, 24, 1213-1220.
95. Chajes, V.; Thiebaut, A.C., Rotival, M.; Gauthier, E.; Maillard, V.; Boutron-Ruault, M.C.; Joulin, V.; Lenoir, G.M.; Clavel-Chapelon, F. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am. J. Epidemiol. 2008, 167, 1312–1320.
96. Soubry, A.; Murphy, S.K.; Wang, F.; Huang, Z.; Vidal, A.C.; Fuemmeler, B.F.; Kurtzberg, J.; Murtha, A.; Jirtle, R.L.; Schildkraut, J.M.; et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int. J. Obes. (Lond.) 2013, doi:10.1038/ijo.2013.193.
97. Rampersaud, G.C.; Kauwell, G.P.; Hutson, A.D.; Cerda, J.J.; Bailey, L.B. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 2000, 72, 998–1003.
98. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary Polyphenols and the Prevention of Diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306.
99. Li, Y.; Chang, S.C.; Goldstein, B.Y.; Scheider, W.L.; Cai, L.; You, N.C.; Tarleton, H.P.; Ding, B.; Zhao, J.; Wu, M.; et al. Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol. 2011, 35, 362–368.
100. Khan, N.; Mukhtar, H. Cancer and metastasis: Prevention and treatment by green tea. Cancer Metastasis Rev. 2010, 29, 435–445.
101. Steegers-Theunissen, R.P.; Twigt, J.; Pestinger, V.; Sinclair, K.D. The periconceptional period, reproduction and long-term health of offspring: The importance of one-carbon metabolism. Hum. Reprod. Update 2013, 19, 640–655.
102. Zeisel, S.H. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am. J. Clin. Nutr. 2009, 89, 1488S–1493S.
103. Chang, H.; Zhang, T.; Zhang, Z.; Bao, R.; Fu, C.; Wang, Z.; Bao, Y.; Li, Y.; Wu, L.; Zheng, X.; et al. Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J. Nutr. Biochem. 2011, 22, 1172–1177.
104. Van den Donk, M.; Pellis, L.; Crott, J.W.; van Engeland, M.; Friederich, P.; Nagengast, F.M.; van Bergeijk, J.D.; de Boer, S.Y.; Mason, J.B.; Kok, F.J.; et al. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas. J. Nutr. 2007, 137, 2114–2120.
105. Choi, S.W.; Friso, S. Epigenetics: A New Bridge between Nutrition and Health. Adv. Nutr. 2010, 1, 8–16.
106. Chen, J.; Gammon, M.D.; Chan, W.; Palomeque, C.; Wetmur, J.G.; Kabat, G.C.; Teitelbaum, S.L.; Britton, J.A.; Terry, M.B.; Neugut, A.I.; et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 2005, 65, 1606–1614.
107. Kim, Y.I. Folate and colorectal cancer: An evidence-based critical review. Mol. Nutr. Food Res. 2007, 51, 267–292.
108. James, S.J.; Pogribny, I.P.; Pogribna, M.; Miller, B.J.; Jernigan, S.; Melnyk, S. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J. Nutr. 2003, 133, 3740S–3747S.
109. Trasler, J.; Deng, L.; Melnyk, S.; Pogribny, I.; Hiou-Tim, F.; Sibani, S.; Oakes, C.; Li, E.; James, S.J.; Rozen, R. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003, 24, 39–45.
110. Lelievre, S.A. Contributions of extracellular matrix signaling and tissue architecture to nuclear mechanisms and spatial organization of gene expression control. Biochim. Biophys. Acta 2009, 1790, 925–935.
111. Stempak, J.M.; Sohn, K.J.; Chiang, E.P.; Shane, B.; Kim, Y.I. Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 2005, 26, 981–990.
112. Song, J.; Medline, A.; Mason, J.B.; Gallinger, S.; Kim, Y.I. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res. 2000, 60, 5434–5440.
113. Supic, G.; Jovic, N.; Kozomara, R.; Zeljic, K.; Magic, Z. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes. J. Dent. Res. 2011, 90, 65–70.
114. Frisco, S.; Choi, S.W.; Girelli, D.; Mason, J.B.; Dolnikowski, G.G.; Bagley, P.J.; Olivieri, O.; Jacques, P.F.; Rosenberg, I.H.; Corrocher, R.; et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA 2002, 99, 5606–5611.
115. Van Engeland, M.; Weijenberg, M.P.; Roemen, G.M.; Brink, M.; de Bruine, A.P.; Goldbohm, R.A.; van den Brandt, P.A.; Baylin, S.B.; de Goeij, A.F.; Herman, J.G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res. 2003, 63, 3133–3137.
116. Shrubsole, M.J.; Shu, X.O.; Li, H.-L.; Cai, H.; Yang, G.; Gao, Y.-T.; Gao, J.; Zheng, W. Dietary B Vitamin and Methionine Intakes and Breast Cancer Risk Among Chinese Women. Am. J. Epidemiol. 2011, 173, 1171–1182.
117. Duthie, S.J. Folate and cancer: How DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 2011, 34, 101–109.
118. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747.
119. Mantena, S.K.; Meeran, S.M.; Elmets, C.A.; Katiyar, S.K. Orally Administered Green Tea Polyphenols Prevent Ultraviolet Radiation-Induced Skin Cancer in Mice through Activation of Cytotoxic T Cells and Inhibition of Angiogenesis in Tumors. J. Nutr. 2005, 135, 2871–2877.
120. Yang, C.S.; Landau, J.M.; Huang, M.T.; Newmark, H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001, 21, 381–406.
121. Paluszczak, J.; Krajka-Kuzniak, V.; Baer-Dubowska, W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol. Lett. 2010, 192, 119–125.
122. Binda, O.; Nassif, C.; Branton, P.E. SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins. Oncogene 2008, 27, 3384–3392.
123. Ndiaye, M.; Kumar, R.; Ahmad, N. Resveratrol in cancer management: Where are we and where we go from here? Ann. N. Y. Acad. Sci. 2011, 1215, 144–149.
124. Fang, M.; Chen, D.; Yang, C.S. Dietary Polyphenols May Affect DNA Methylation. J. Nutr. 2007, 137, 223S–228S.
125. Geybels, M.S.; Neuhouser, M.L.; Wright, J.L.; Stott-Miller, M.; Stanford, J.L. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control 2013, 24, 1947–1954.
126. De, P.; Baltas, M.; Bedos-Belval, F. Cinnamic Acid Derivatives as Anticancer Agents-A Review. Curr. Med. Chem. 2011, 18, 1672–1703.
127. Constantinou, A.I.; Lantvit, D.; Hawthorne, M.; Xu, X.; van Breemen, R.B.; Pezzuto, J.M. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr. Cancer 2001, 41, 75–81.
128. Duffy, C.; Cyr, M. Phytoestrogens: Potential Benefits and Implications for Breast Cancer Survivors J. Women’s Health 2003, 12, 617–631.
129. Korde, L.A.; Wu, A.H.; Fears, T.; Nomura, A.M.; West, D.W.; Kolonel, L.N.; Pike, M.C.; Hoover, R.N.; Ziegler, R.G. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol. Biomark. Prev. 2009, 18, 1050–1059.
130. Thanos, J.; Cotterchio, M.; Boucher, B.A.; Kreiger, N.; Thompson, L.U. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 2006, 17, 1253–1261.
131. Qin, W.; Zhu, W.; Shi, H.; Hewett, J.E.; Ruhlen, R.L.; MacDonald, R.S.; Rottinghaus, G.E.; Chen, Y.-C.; Sauter, E.R. Soy Isoflavones Have an Antiestrogenic Effect and Alter Mammary Promoter Hypermethylation in Healthy Premenopausal Women. Nutr. Cancer 2009, 61, 238–244.
132. Desjobert, C.; Renalier, M.H.; Bergalet, J.; Dejean, E.; Joseph, N.; Kruczynski, A.; Soulier, J.; Espinos, E.; Meggetto, F.; Cavaille, J.; et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011, 117, 6627–6637.
133. Lippman, S.M.; Klein, E.A.; Goodman, P.J.; Lucia, M.S.; Thompson, I.M.; Ford, L.G.; Parnes, H.L.; Minasian, L.M.; Gaziano, J.M.; Hartline, J.A.; et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301, 39–51.
134. Clark, L.C.; Combs, G.F., Jr.; Turnbull, B.W.; Slate, E.H.; Chalker, D.K.; Chow, J.; Davis, L.S.; Glover, R.A.; Graham, G.F.; Gross, E.G.; et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276, 1957–1963.
135. Lee, S.O.; Yeon Chun, J.; Nadiminty, N.; Trump, D.L.; Ip, C.; Dong, Y.; Gao, A.C. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 2006, 66, 1070–1075.
136. Unni, E.; Koul, D.; Yung, W.K.; Sinha, R. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Breast Cancer Res. Treat. 2005, 7, R699–R707.
137. Tsavachidou, D.; McDonnell, T.J.; Wen, S.; Wang, X.; Vakar-Lopez, F.; Pisters, L.L.; Pettaway, C.A.; Wood, C.G.; Do, K.A.; Thall, P.F.; et al. Selenium and vitamin E: Cell type- and intervention-specific tissue effects in prostate cancer. J. Natl. Cancer Inst. 2009, 101, 306–320.
138. Lee, J.-I.; Nian, H.; Cooper, A.J.L.; Sinha, R.; Dai, J.; Bisson, W.H.; Dashwood, R.H.; Pinto, J.T. α-Keto Acid Metabolites of Naturally Occurring Organoselenium Compounds as Inhibitors of Histone Deacetylase in Human Prostate Cancer Cells. Cancer Prev. Res. 2009, 2, 683–693.
139. Arikawa, A.Y.; Gallaher, D.D. Cruciferous vegetables reduce morphological markers of colon cancer risk in dimethylhydrazine-treated rats. J. Nutr. 2008, 138, 526–532.
140. Suzuki, R.; Iwasaki, M.; Hara, A.; Inoue, M.; Sasazuki, S.; Sawada, N.; Yamaji, T.; Shimazu, T.; Tsugane, S.; Japan Public Health Center-based Prospective Study Group. Fruit and vegetable intake and breast cancer risk defined by estrogen and progesterone receptor status: The JPHC study. Cancer Causes Control 2013, 24, 2117–2128.
141. Traka, M.; Gasper, A.V.; Smith, J.A.; Hawkey, C.J.; Bao, Y.; Mithen, R.F. Transcriptome analysis of human colon Caco-2 cells exposed to sulforaphane. J. Nutr. 2005, 135, 1865–1872.
142. Hsu, A.; Wong, C.P.; Yu, Z.; Williams, D.E.; Dashwood, R.H.; Ho, E. Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin. Epigenetics 2011, 3, 3.
143. Meeran, S.M.; Patel, S.N.; Li, Y.; Shukla, S.; Tollefsbol, T.O. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS One 2012, 7, e37748.
144. Banwell, C.M.; MacCartney, D.P.; Guy, M.; Miles, A.E.; Uskokovic, M.R.; Mansi, J.; Stewart, P.M., O’Neill, L.P.; Turner, B.M.; Colston, K.W.; et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2006, 12, 2004–2013.
145. Luo, W.; Karpf, A.R.; Deeb, K.K.; Muindi, J.R.; Morrison, C.D.; Johnson, C.S.; Trump, D.L. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Res. 2010, 70, 5953–5962.
146. Trump, D.L.; Muindi, J.; Fakih, M.; Yu, W.-D.; Johnson, C.S. Vitamin D Compounds: Clinical Development as Cancer Therapy and Prevention Agents. Anticancer Res. 2006, 26, 2551–2556.
147. Kim, M.S.; Fujiki, R.; Kitagawa, H.; Kato, S. 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene. Mol. Cell Endocrinol. 2007, 265–266, 168–173.
148. McGregor, L.M.; McCune, B.K.; Graff, J.R.; McDowell, P.R.; Romans, K.E.; Yancopoulos, G.D.; Ball, D.W.; Baylin, S.B.; Nelkin, B.D. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc. Natl. Acad. Sci. USA 1999, 96, 4540–4545
149. Au, C.W.H.; Siu, M.K.Y.; Liao, X.; Wong, E.S.Y.; Ngan, H.Y.S.; Tam, K.F.; Chan, D.C.W.; Chan, Q.K.Y.; Cheung, A.N.Y. Tyrosine kinase B receptor and BDNF expression in ovarian cancers— Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett. 2009, 281, 151–161.
150. Bistulfi, G.; Pozzi, S.; Ren, M.; Rossetti, S.; Sacchi, N. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: Implications for predicting breast cancer risk. Cancer Res. 2006, 66, 10308–10314.
151. Deeb, K.K.; Luo, W.; Karpf, A.R.; Omilian, A.R.; Bshara, W.; Tian, L.; Tangrea, M.A.; Morrison, C.D.; Johnson, C.S.; Trump, D.L. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate. Epigenetics Off. J. DNA Methylation Soc. 2011, 6, 994–1000.
152. King-Batoon, A.; Leszczynska, J.M.; Klein, C.B. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen. 2008, 49, 36–45.
153. Ferlay, J.; Shin, H.-R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer J. Int. Cancer 2010, 127, 2893–2917.
154. Burdge, G.C.; Slater-Jefferies, J.; Torrens, C.; Phillips, E.S.; Hanson, M.A.; Lillycrop, K.A. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br. J. Nutr. 2007, 97, 435–439.
155. Rantakallio, P. The longitudinal study of the Northern Finland birth cohort of 1966. Paediatr. Perinat. Epidemiol. 1988, 2, 59–88.
156. Morton, S.M.B.; Atatoa Carr, P.E.; Grant, C.C.; Robinson, E.M.; Bandara, D.K.; Bird, A.; Ivory, V.C.; Kingi, T.K.R.; Liang, R.; Marks, E.J.; et al. Cohort Profile: Growing Up in New Zealand. Int. J. Epidemiol. 2013, 42, 65–75.